The BRAF (V600E) mutation in colorectal cancers that are microsatellite stable (MSS)
confers a poor patient prognosis, whereas BRAF mutant microsatellite-unstable (MSI) …

The BRAF oncogene is mutated in 15% of sporadic colorectal cancers. Approximately half of
these BRAF mutant cancers demonstrate frequent frameshift mutations termed microsatellite …

Microsatellite instability (MSI) has been associated with favourable survival in early stage
colorectal cancer (CRC) compared to microsatellite stable (MSS) CRC. The BRAF V600E …

BRAF mutation in colorectal cancer is associated with microsatellite instability (MSI) through
its relationship with high-level CpG island methylator phenotype (CIMP) and MLH1 promoter …

Purpose The aim of this study was to investigate the prognostic value of the combination of
microsatellite instability (MSI) and BRAF V600E mutation in colorectal cancer (CRC) …

Background: The objective of the study was to examine the role of microsatellite instability
(MSI) and BRAF V600E mutation in colorectal cancer (CRC) by categorising patients into …

Background & Aims Colorectal tumors with mutations in BRAF and microsatellite stability
(MSS) have been associated with adverse outcomes of patients. Combined tests for …

3597 Background: Colorectal cancer (CRC) displaying high levels of microsatellite instability
(MSI-H) has been associated with improved survival in colorectal cancer. MSI-H CRC is also …

Abstract Background Microsatellite stable (MSS) BRAF p. V600E mutation colorectal cancer
(BRAF-CRC) has a poor prognosis, whereas microsatellite instability (MSI) in BRAF-CRC is …

Reduced CDX2 and cytokeratin 20 (CK20) expression in colorectal carcinoma with BRAF
mutation and high-level microsatellite instability (MSI-H) has been well documented. The …